This content is machine translated Advanced breast cancer Next-generation SERD therapy with promising results The results of the Phase III EMBER-3 trial of imlunestrant, a next-generation oral selective oestrogen receptor degrader (SERD) for patients with hormone receptor-positive breast cancer in ER-positive, HER2-negative advanced breast...…
View Post 6 min This content is machine translated Breast Cancer Latest findings around breast cancer research International experts have been meeting annually since 1977 to share current information on breast cancer research. The goal is to balance clinical, translational, and basic research and to provide a…
View Post 9 min This content is machine translated Locally advanced/metastatic breast carcinoma 44th San Antonio Breast Cancer Symposium: Best Of From December 7-10, 2021, the 44th San Antonio Breast Cancer Symposium took place in a physical-virtual hybrid event. In a series of exciting lectures, the latest clinical and preclinical findings…
View Post 4 min This content is machine translated Prevention and treatment of ER-positive breast cancer IBIS-1 update shows promising results At the San Antonio Breast Cancer Symposium, people discussed prevention options for women at high risk for breast cancer. Tamoxifen continues to show a significant reduction in the incidence of…
